Fletcher AP, Alkjaersig N., Smyrniotis FE, Sherry S.The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Phys1958; 71: 287-96.
2.
Gissi.Effectiveness of intravenous treatment in acute myocardial infarction. Lancet1986; i: 397-402.
3.
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected myocardial infarction: ISIS-2. Lancet1988 ; ii: 349-60.
4.
Burrell CJ, Skehan JD, Cowley ML, Barrett CW, Mills PGDistricts' use of thrombolytic agents. Br Med J1990; 300: 237-38.
5.
Garraway WM, Akhtar AJ, Prescott RJ, Hockey L.Management of acute stroke in the elderly: preliminary results of a controlled trial. Br Med J1980; 280: 1040-43.
6.
Schwartz D., Lellouch J.Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis1967; 20: 637-48.
7.
Howard D.Beyond randomised controlled trials: the case for effective case studies of the effects of treatment in aphasia. Br J Disord Commun1986; 21: 89-102.
8.
World Health Organization.International classification of impairments, disabilities and handicaps. Geneva: World Health Organization, 1980.
9.
Ebrahim SB, Nouri F., Barer D.Measuring disability after a stroke. J Epidemiol Community Health1985; 39:86-89.
10.
Nouri F., Lincoln NBAn extended activities of daily living scale for stroke patients. Clin Rehabil1987; 1: 301-305.
11.
Bamford JM, Sandercock Pag, Warlow CP, Slattery J.Interobserver agreement for the assessment of handicap in stroke patients . Stroke.1989; 20: 828.
12.
Bergner M., Bobbitt RA, Carter WB, Gilson BSThe Sickness Impact Profile: development and final revision of a health status measure. Med Care1981; 19: 787-805.
Warlow C.How to organise a multicentre trial. Br Med J1990; 300: 180-83.
21.
Fitz-Gibbon CTIn defence of randomised controlled trials, with suggestions about the possible use of meta-analysis. Br J Disord Commun1986; 21: 117-24.